Items where Author is "Neven, P."
Number of items: 2. 2015Zaman, K. and Winterhalder, R. and Mamot, C. and Hasler-Strub, U. and Rochlitz, C. and Mueller, A. and Berset, C. and Wiliders, H. and Perey, L. and Rudolf, C. B. and Hawle, H. and Rondeau, S. and Neven, P.. (2015) Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08. European Journal of Cancer, 51 (10). pp. 1212-1220. 2014Vulsteke, C. and Pfeil, A. M. and Schwenkglenks, M. and Pettengell, R. and Szucs, T. D. and Lambrechts, D. and Peeters, M. and van Dam, P. and Dieudonné, A. S. and Hatse, S. and Neven, P. and Paridaens, R. and Wildiers, H.. (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment, Vol. 147, H. 3. pp. 557-570. |
